1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Human Microbiome Market – By Product
1.3.2 Global Human Microbiome Market – by Disease
1.3.3 Global Human Microbiome Market – by Application
1.3.4 Global Human Microbiome Market – By Geography

2. Human Microbiome Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Human Microbiome Market – Market Landscape
4.1 Overview
4.1.1 North America – PEST Analysis
4.1.2 Europe– PEST Analysis
4.1.3 Asia Pacific– PEST Analysis
4.1.4 Middle East And Africa– PEST Analysis
4.1.5 South and Central America – PEST Analysis
4.2 Expert Opinions

5. Human Microbiome Market– Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Incidence of Lifestyle Diseases
5.1.2 Increasing Focus On Human Microbiome Therapies
5.1.3 Growing Technological Advancements in Metagenomics and Next-generation Sequencing
5.2 Key Market Restraints
5.2.1 Strict Government Guidelines
5.2.2 Lack of Knowledge and Detailed Examination
5.3 Key Market Opportunities
5.3.1 New Drug Requirements for Faecal Microbiota
5.3.2 Emerging Nations
5.4 Future Trends
5.4.1 The Human Microbiome - A New Frontier in Drug Discovery
5.5 Impact analysis

6. Human Microbiome Market – Global Analysis
6.1 Global Human Microbiome Market Revenue Forecast and Analysis
6.2 Global Human Microbiome Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Human Microbiome Market Analysis – By Product
7.1 Overview
7.2 Human Microbiome Market Revenue Share, by Product (2019 and 2027)
7.3 Foods
7.3.1 Overview
7.3.2 Foods: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Medical Food
7.4.1 Overview
7.4.2 Medical Food: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Probiotics
7.5.1 Overview
7.5.2 Probiotics: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Drugs
7.6.1 Overview
7.6.2 Drugs: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Diagnostic Devices
7.7.1 Overview
7.7.2 Diagnostic Devices: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Supplements
7.8.1 Overview
7.8.2 Supplements: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)

8. Human Microbiome Market Analysis – By Disease
8.1 Overview
8.2 Human Microbiome Market Revenue Share, by Disease(2019 and 2027)
8.3 Diabetes
8.3.1 Overview
8.3.2 Global Diabetes Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Cancer
8.4.1 Overview
8.4.2 Global Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Autoimmune Disorders
8.5.1 Overview
8.5.2 Global Autoimmune Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Obesity
8.6.1 Overview
8.6.2 Global Obesity Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Mental Disorders
8.7.1 Overview
8.7.2 Global Mental Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others Market
8.8.1 Overview
8.8.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

9. Human Microbiome Market Analysis – By Application
9.1 Overview
9.2 Human Microbiome Market Revenue Share, by Application(2019 and 2027)
9.3 Diagnostics
9.3.1 Overview
9.3.2 Diagnostics:Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Therapeutics
9.4.1 Overview
9.4.2 Therapeutics:Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)

10. Human Microbiome Market Analysis and Forecasts To 2027 Geographical Analysis
10.1 North America: Human Microbiome Market
10.1.1 Overview
10.1.2 North America: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.1.4 North America: Human Microbiome Market, by Disease, 2018–2027 (USD Million)
10.1.5 North America: Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.1.6 North America: Human Microbiome Market, by Country, 2019 & 2027 (%)
10.1.7 US: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.1.7.3 US: Human Microbiome Market, by Disease, 2018–2027 (USD Million)
10.1.7.4 US: Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.1.8 Canada: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.1.8.3 Canada: Human Microbiome Market, by Disease, 2018–2027 (USD Million)
10.1.8.4 Canada: Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.1.9 Mexico: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.1.9.3 Mexico: Human Microbiome Market, by Disease, 2018–2027 (USD Million)
10.1.9.4 Mexico: Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.2 Europe: Human Microbiome Market
10.2.1 Overview
10.2.2 Europe: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
10.2.5 Europe Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Human Microbiome Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
10.2.7.4 Germany Human Microbiome Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.2.8 UK: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.8.3 UKHuman Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.2.8.4 UK: Human Microbiome Market, Usability – Revenue and Forecast to 2027 (USD Million)
10.2.9 France: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.9.3 France Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
10.2.9.4 France Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.10 Spain: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Spain Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.2.10.4 Spain Human Microbiome Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.2.11 Italy: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Italy Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Italy Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Human Microbiome Market
10.3.1 Overview
10.3.2 Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.3.4 Asia Pacific: Human Microbiome Market, by Disease, 2018–2027 (USD Million)
10.3.5 Asia Pacific: Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.3.6 Asia Pacific: Human Microbiome Market, by Country, 2018 & 2027 (%)
10.3.7 China: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.3.7.3 ChinaHuman Microbiome Market, by Disease, 2018–2027 (USD Million)
10.3.7.4 China Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.3.8 Japan: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.3.8.3 JapanHuman Microbiome Market, by Disease, 2018–2027 (USD Million)
10.3.8.4 JapanHuman Microbiome Market, by Application, 2018–2027 (USD Million)
10.3.9 India: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.3.9.3 IndiaHuman Microbiome Market, by Disease, 2018–2027 (USD Million)
10.3.9.4 IndiaHuman Microbiome Market, by Application, 2018–2027 (USD Million)
10.3.10 South Korea: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.3.10.3 South KoreaHuman Microbiome Market, by Disease, 2018–2027 (USD Million)
10.3.10.4 South KoreaHuman Microbiome Market, by Application, 2018–2027 (USD Million)
10.3.11 Australia: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.3.11.4 Australia Human Microbiome Market, by Disease, 2018–2027 (USD Million)
10.3.11.5 Australia Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.4 Middle East & Africa: Human Microbiome Market
10.4.1 Overview
10.4.2 Middle East & Africa: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East & Africa Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa Human Microbiome Market, by Application– Revenue and Forecast to 2027(USD Million)
10.4.6 Middle East & Africa: Human Microbiome Market, by Country, 2019& 2027 (%)
10.4.6.1 Saudi Arabia: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.4.6.2 Saudi Arabia: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.4.6.3 Saudi Arabia Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.4.6.4 Saudi Arabia Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.4.6.5 Saudi Arabia Human Microbiome Market, by Application– Revenue and Forecast to 2027(USD Million)
10.4.7 UAE: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 UAE: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 UAE Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.4.7.3 UAE Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.4.7.4 UAE Human Microbiome Market, by Application– Revenue and Forecast to 2027(USD Million)
10.4.8 South Africa: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 South Africa: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 South Africa Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.4.8.3 South Africa Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.4.8.4 South Africa Human Microbiome Market, by Application– Revenue and Forecast to 2027(USD Million)
10.5 South and Central America: Human Microbiome Market
10.5.1 Overview
10.5.2 South and Central America: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America Human Microbiome Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Human Microbiome Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Brazil Human Microbiome Market, by Application– Revenue and Forecast to 2027(USD Million)
10.5.8 Argentina: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.5.8.4 Argentina Human Microbiome Market, by Application– Revenue and Forecast to 2027(USD Million)

11. Impact of COVID-19 Pandemic on Global Human Microbiome Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Human Microbiome Market – Industry Landscape
12.1 Growth Strategies in the Human Microbiome Market, 2015-2020
12.2 Organic Growth Strategies
12.2.1 Overview
12.2.2 Product Launch & Approvals
12.2.3 Expansion
12.2.4 Patent and license
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.3.2 Acquisitions
12.3.3 Partnerships, Collaborations & Agreements
12.3.4 Joint Ventures

13. Company Profiles
13.1 ENTEROME
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Rebiotix Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Yakult Honsha Co., Ltd.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Osel Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product Portfolio
13.4.5 Swot Analysis
13.4.6 Key Developments
13.5 Vedanta Biosciences, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Information
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Synthetic Biologics, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Information
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 DuPont
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BiomX
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Information
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 MaaT Pharma
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ELIGO BIOSCIENCE
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 AOBiome
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Kaleido Biosciences, Inc.
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Seres Therapeutics
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Merck & Co., Inc.
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments

14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF FIGURES
Figure 1. Human Microbiome Market Segmentation
Figure 2. Human Microbiome Market Segmentation, By Region
Figure 3. Human Microbiome Market Overview
Figure 4. Probiotics Segment Held Largest Share of Human Microbiome Market
Figure 5. Asia-Pacific to Show Significant Growth During Forecast Period
Figure 6. Human Microbiome Market, by Geography (US$ Million)
Figure 7. Global Human Microbiome Market – Leading Country Markets (US$ Million)
Figure 8. North America PEST Analysis
Figure 9. Europe PEST Analysis
Figure 10. Asia pacific PEST Analysis
Figure 11. Middle East and Africa PEST Analysis
Figure 12. South and Central America PEST Analysis
Figure 13. Human Microbiome Market Impact Analysis of Driver and Restraints
Figure 14. Global Human Microbiome Market – Revenue Forecast And Analysis – 2019- 2027
Figure 15. Global Human Microbiome Market – By Geography Forecast and Analysis – 2019- 2027
Figure 16. Market Positioning Of Key Players In Global Human Microbiome Market
Figure 17. Human Microbiome Market Revenue Share, by Product (2019 and 2027)
Figure 18. Foods: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Medical Food: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Probiotics: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Drugs: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Diagnostic Devices: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Supplements: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Human Microbiome Market Revenue Share, by Disease(2019 and 2027)
Figure 25. Global Diabetes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Global Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Global Autoimmune Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Global Obesity Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Global Mental Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. Human Microbiome Market Revenue Share, by Application(2019 and 2027)
Figure 32. Diagnostics: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Therapeutics: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. North America: Human Microbiome Market, by Key Country – Revenue (2019) (USD Million)
Figure 35. North America Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
Figure 36. North America: Human Microbiome Market, by Country, 2019 & 2027 (%)
Figure 37. US: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Canada: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Mexico: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. Europe: Human Microbiome Market, by Key Country – Revenue (2019) (USD Million)
Figure 41. Europe Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
Figure 42. Europe: Human Microbiome Market, by Country, 2019 & 2027 (%)
Figure 43. Germany: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. UK: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. France: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. Spain: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. Italy: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 48. Asia Pacific: Human Microbiome Market, by Key Country – Revenue (2019) (USD Million)
Figure 49. Asia Pacific Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
Figure 50. China: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Japan: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. India: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. South Korea: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. Australia: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. Middle East & Africa: Human Microbiome Market, by Key Country – Revenue (2019) (USD Million)
Figure 56. Middle East & Africa Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
Figure 57. Middle East & Africa: Human Microbiome Market, by Country, 2019 & 2027 (%)
Figure 58. Saudi Arabia: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. UAE: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. South Africa: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 61. South and Central America: Human Microbiome Market, by Key Country – Revenue (2019) (USD Million)
Figure 62. South and Central America Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
Figure 63. South and Central America: Human Microbiome Market, by Country, 2019 & 2027 (%)
Figure 64. Brazil: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. Argentina: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 66. Impact of COVID-19 Pandemic in North American Country Markets
Figure 67. Impact of COVID-19 Pandemic in European Country Markets
Figure 68. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 69. Impact of COVID-19 Pandemic in Rest of the World Market
Figure 70. Growth Strategies in the Human Microbiome Market, 2015-2020
Figure 71. Organic Growth Strategies in the Human Microbiome Market, 2015-2020
Figure 72. Inorganic Growth Strategies in the Endoscopy Device Market, 2015-2018

LIST OF TABLES
Table 1. North America Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 2. North America Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 4. US Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. US Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 6. US Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 13. Europe Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. Europe Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 15. Europe Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 16. Germany Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 17. Germany Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 18. Germany Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 19. United Kingdom Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 20. UK: Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million).
Table 21. UK: Human Microbiome Market, Usability – Revenue and Forecast to 2027 (USD Million)
Table 22. France Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 23. France Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 24. France Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. Spain Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 26. Spain Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 27. Spain Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 28. Italy Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 29. Italy Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 30. Italy Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 31. Asia Pacific Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 32. Asia Pacific Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 33. Asia Pacific Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 34. China Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 35. China Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 36. China Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 37. Japan Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 38. Japan Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 39. Japan Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 40. India Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 41. India Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 42. India Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 43. South Korea Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 44. South Korea Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 45. South Korea Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 46. Australia Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 47. Australia Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 48. Australia Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 49. Middle East & Africa Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 50. Middle East & Africa Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
Table 51. Middle East & Africa Human Microbiome Market, by Application – Revenue and Forecast to 2027(USD Million)
Table 52. Saudi Arabia Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 53. Saudi Arabia Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 54. Saudi Arabia Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 55. UAE Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 56. UAE Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 57. UAE Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 58. South Africa Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 59. South Africa Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 60. South Africa Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 61. South and Central America Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 62. South and Central America Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 63. South and Central America Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 64. Brazil Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 65. Brazil Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 66. Brazil Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 67. Argentina Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 68. Argentina Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 69. Argentina Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 70. Recent Product Launches & Approvals in the Human Microbiome Market
Table 71. RecentEXPANSIONS in the Human Microbiome Market
Table 72. Patent and License Organic Growth Strategies in the Human Microbiome Market
Table 73. Recent Acquisitions in the Human Microbiome market
Table 74. Recent Partnerships & Collaborations in the Human Microbiome market
Table 75. Joint Ventures inOrganic Growth Strategies in the Human Microbiome Market
Table 76. Glossary of Terms, Human Microbiome Market

The List of Companies - Human Microbiome Market
1. Enterome
2. Rebiotix Inc.
3. Yakult Honsha Co., Ltd.
4. Osel Inc.
5. Vedanta Biosciences, Inc.
6. Synthetic Biologics, Inc.
7. DuPont
8. BiomX Ltd
9. MaaT Pharma
10. Eligo Bioscience
11. Merck & Co., Inc
12. AOBiome LLC
13. Kaleido
14. Seres Therapeutics